Clinical Trial Update: Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil [Phase 4]

View source ↗

Summary

Phase 4 extension study evaluating tolerability and safety of enteric-coated mycophenolate sodium in renal transplant recipients who previously received mycophe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: Novartis | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED